Portal de investigación
ESTUDIO EN FASE 3, ABIERTO Y MULTICÉNTRICO PARA EVALUAR LA EFICACIA Y SEGURIDAD DEL FVIIIR PEGILADO (BAX 855) EN PACIENTES CON HEMOFILIA A SEVERA PREVIAMENTE TRATADOS SOMETIDOS A CIRUGÍA O A OTROS PROCEDIMIENTOS INVASIVOS.
Datos básicos
- Protocolo:
- 261204
- EUDRACT:
- 2013-001359-11
- NCT:
- Centro:
- HOSPITAL UNIVERSITARI I POLITÈCNIC LA FE
- Año de incio:
- 2014
- Año de finalización:
- 2015
Objetivos del proyecto
Observaciones: Estado Comité: FINALIZADO
Documentos
- No hay documentos
Participantes
Financiadores - Promotores
Resultados del Ensayo Clínico
A MODIFICATION OF CALIBRATED AUTOMATED THROMBIN GENERATION ASSAY TO EXPLORE NEW COFACTORS OF ACTIVATED PROTEIN C IN PLASMA
Martos, L.; (...); Navarro Rosales, S.
Meeting Abstract. 10.1016/S0049-3848(14)50233-2. 2014
ACUTE MYELOID LEUKEMIA IN PATIENTS 70 AND ABOVE. AZACITIDINE VERSUS INTENSIVE CHEMOTHERAPY
De La Fuente, A.; (...); Ramos, F.
Meeting Abstract. 2014
Adherence to prophylaxis and quality of life in children and adolescents with severe haemophilia A
García-Dasí M; (...); García-Talavera JA
Article. 10.1111/hae.12618. 2015
Analisis de las causas de suspension de tratamiento con triple terapia antiviral en pacientes con hepatitis C.
Ruiz Ramos J; (...); Poveda Andrés JL
Abstract of Published Item. 10.7399/fh.2014.38.3.1171. 2014
Analysis of 65 pregnancies in 34 women with five different forms of inherited platelet function disorders
Civaschi E; (...); European Haematology Association - Scientific Working Group on Thrombocytopenias
Article. 10.1111/bjh.13458. 2015
Anidulafungin-Induced Alopecia
Ruiz-Ramos J; (...); Poveda-Andrés JL
Article. 10.1177/1060028014524534. 2014
Association of SNPs with the efficacy and safety of immunosuppressant therapy after heart transplantation
Sánchez-Lázaro I; (...); Aliño SF
Article. 10.2217/pgs.15.39. 2015
Azacitidine in older patients with acute myeloid leukemia (AML). Results from the ALMA study according to the MRC risk index score.
Falantes, Jose F.; (...); Ramos, Fernando
Meeting Abstract. 2015
Biosimilares: viejas polemicas con nuevos argumentos.
Poveda-Andrés JL, Bosó-Ribelles V
Editorial Material. 10.7399/fh.2015.39.3.8978. 2015
Bleeding before prophylaxis in severe hemophilia: paradigm shift over two decades
Nijdam A; (...); PedNet and CANAL study groups
Letter. 10.3324/haematol.2014.115709. 2015
Calidad y Legibilidad de la Hoja de Informacion al Paciente en Estudios con Analisis Farmacogenetico.
Ruiz Ramos J; (...); Poveda Andrés JL
Article. 2015
Clinical experiences with cannabinoids in spasticity management in multiple sclerosis
Lorente Fernández L; (...); Casanova-Estruch B
Article. 10.1016/j.nrl.2013.06.014. 2014
CLINICAL OUTCOMES OF ACUTE ERYTHROLEUKEMIA TREATED WITH AZACITIDINE: A RETROSPECTIVE MULTICENTER STUDY
Almeida, A.; (...); Pleyer, L.
Meeting Abstract. 2015
COMBINED DEFICIENCY OF PROTEIN C, PROTEIN S AND ANTITHROMBIN IN PATIENTS WITH MESENTERIC OR PORTAL VENOUS THROMBOSIS WITH OR WITHOUT HEPATIC CIRRHOSIS
Martos, L.; (...); Espana, F.
Meeting Abstract. 10.1016/S0049-3848(14)50197-1. 2014
Cost-effectiveness of methoxy polyethylene glycolepoetin beta versus conventional epoetin in the treatment of anaemia secondary to chronic kidney disease in clinical practice
Lorente-Fernandez, L; (...); Poveda-Andres, JL
Article. 10.1136/ejhpharm-2013-000426. 2015
Development and psychometric validation of a brief comprehensive health status assessment scale in older patients with hematological malignancies: The GAH Scale
Bonanad S; (...); GAH Group
Article. 10.1016/j.jgo.2015.03.003. 2015
DIFFERENT CLINICAL MANIFESTATION OF DYSFIBRINOGENEMIAS ASSOCIATED TO THE MUTATION ARG275 IN EXON 8 OF FGG GENE
Mesa, E.; (...); Bonanad, S.
Meeting Abstract. 10.1016/S0049-3848(14)50268-X. 2014
Dose banding aplicado a la elaboracion de antineoplasicos: una revision narrativa de la literatura.
Pérez Huertas P; (...); Poveda Andrés JL
Article. 10.7399/fh.2015.39.4.8839. 2015
Drug Interaction Between Oral Cyclosporine Modified and Iron
Domingo-Chiva, E; (...); Poveda-Andres, JL
Article. 10.1177/1060028013514734. 2014
ECONOMIC IMPACT LINKED TO THE REDUCTION OF EXACERBATIONS WHEN A TREATMENT REGIME WITH INHALED ANTIBIOTICS IS SWITCHED TO AZTREONAM LYSINE IN PATIENTS WITH CYSTIC FIBROSIS AND CHRONIC PULMONARY INFECTION CAUSED BY PSEUDOMONAS AERUGINOSA
Sole A; (...); Casado MA
Meeting Abstract. 10.1016/j.jval.2014.08.1659. 2014
Effect of CYP3A5*3 on kidney transplant recipients treated with tacrolimus: a systematic review and meta-analysis of observational studies
Rojas L; (...); Aliño SF
Article. 10.1038/tpj.2014.38. 2015
Estudio de utilizacion de boceprevir y telaprevir para el tratamiento de la hepatitis C cronica.
Marrero-Álvarez P; (...); Poveda-Andrés JL
Abstract of Published Item. 10.7399/FH.2014.38.1.1128. 2014
Experience in the management of immunosuppressant treatment with hepatitis C virus protease inhibitors
Ruiz Ramos J; (...); Poveda Andrés JL
Article. 10.1016/j.gastrohep.2014.05.004. 2014
FUNCTIONAL ANALYSIS OF TWO HAPLOTYPES OF THE HUMAN ENDOTHELIAL PROTEIN C RECEPTOR GENE (PROCR)
Bonet, E.; (...); Navarro Rosales, S.
Meeting Abstract. 10.1016/S0049-3848(14)50053-9. 2014
Functional and molecular characterization of inherited platelet disorders in the Iberian Peninsula: results from a collaborative study
Sánchez-Guiu I; (...); Lozano ML
Article. 10.1186/s13023-014-0213-6. 2014
Genotype and Allele Frequencies of Drug-Metabolizing Enzymes and Drug Transporter Genes Affecting Immunosuppressants in the Spanish White Population
Bosó V; (...); Aliño SF
Article. 10.1097/FTD.0b013e3182a94e65. 2014
HIDDEN MDS: A PROSPECTIVE STUDY TO CONFIRM OR EXCLUDE MDS IN PATIENTS WITH ANEMIA OF UNCERTAIN ETIOLOGY
Lopez Godino, O.; (...); Diez Campelo, M.
Meeting Abstract. 2015
HIDDEN MDS: A PROSPECTIVE STUDY TO CONFIRM OR EXCLUDE MDS IN PATIENTS WITH ANEMIA OF UNCERTAIN ETIOLOGY
Lopez-Godino, O.; (...); Diez Campelo, M.
Meeting Abstract. 10.1016/S0145-2126(15)30309-X. 2015
Home-delivered ultrasound monitoring for home treatment of haemarthrosis in haemophilia A
Letter. 10.1111/hae.12622. 2015
Identification and validation of plasma micrornas involved in venous and arterial thrombosis
Ramon, L. A.; (...); Navarro, S.
Meeting Abstract. 2015
IDENTIFICATION OF 6 MUTATIONS IN THE PROTEIN C GENE (PROC) IN A PANEL OF 83 SPANISH FAMILIES WITH PROTEIN C DEFICIENCY
Martos, L.; (...); Espana, F.
Meeting Abstract. 10.1016/S0049-3848(14)50254-X. 2014
IDENTIFICATION OF A PLASMA MICRORNAS PROFILE INVOLVED IN VENOUS THROMBOSIS
Navarro, S.; (...); Espana, F.
Meeting Abstract. 10.1016/S0049-3848(14)50271-X. 2014
Impact of Single Nucleotide Polymorphisms (SNPs) on Immunosuppressive Therapy in Lung Transplantation
Ruiz J; (...); Aliño SF
Article. 10.3390/ijms160920168. 2015
Incompatibility of undiluted busulfan injection with a needle-free valve
Cueto-Sola, M; (...); Poveda-Andres, JL
Letter. 10.2146/ajhp140111. 2014
Increased circulating dna, calprotectin and mieloperoxidase, as neutrophil extracellular trap markers, are risk factors for deep vein thrombosis
Martos, L.; (...); Medina, P.
Meeting Abstract. 2015
Individualization of prophylaxis with recombinant factor VIII in severe or moderate hemophilia A
Vericat, JEM; (...); Bonanad, S
Meeting Abstract. 2018
Individualized Prophylactic Treatment with Recombinant Factor VIII in Severe or Moderate Haemophilia a Patients. Association Between Pharmacokinetic Parameters and Clinical Variables
Megias-Vericat, Juan Eduardo; (...); Bonanad, Santiago
Meeting Abstract. 10.1182/blood.V128.22.3802.3802. 2016
Influence of ABCB1 polymorphisms upon the effectiveness of standard treatment for acute myeloid leukemia: A systematic review and meta-analysis of observational studies
Megías-Vericat JE; (...); Aliño SF
Review. 10.1038/tpj.2014.80. 2015
Inhibitor development after switching of FVIII concentrate in multitransfused patients with severe haemophilia A
Article. 10.1111/hae.12439. 2014
Modification of a thrombin generation test to identify new cofactors of the protein C pathway in plasma
Martos, L.; (...); Navarro, S.
Meeting Abstract. 2015
Monitoring drug activity of dabigatran and rivaroxaban by thrombin generation using the calibrated automated thrombinoscope
Moret, A.; (...); Bonanad, S.
Meeting Abstract. 2015
Multivariable time-dependent analysis of the impact of azacitidine in patients with lower-risk myelodysplastic syndrome and unfavorable specific lower-risk score
Falantes J; (...); Sanz G
Article. 10.1016/j.leukres.2014.10.004. 2015
Muscle strength in load-bearing joints in haemophilic patients: comparative values with the general population
Bonanad-Boix, S.; (...); Querol, F.
Meeting Abstract. 2015
Novel investigations on the protective role of the FVIII/VWF complex in inhibitor development
Mannucci PM; (...); Klamroth R
Review. 10.1111/hae.12465. 2014
Novel investigations on the protective role of the FVIII/VWF complex in inhibitor development (vol 20, pg 2, 2014)
Mannucci, P. M.; (...); Klamroth, R.
Correction. 10.1111/hae.12510. 2014
PATIENT WITH CONGENITAL AFIBRINOGENEMIA AND PERIPHERAL ARTERIAL THROMBOSIS. THERAPEUTIC ANTITHROMBOTIC MANAGEMENT BASED ON MONITORING
Moscardo, A.; (...); Valles, J.
Meeting Abstract. 10.1016/S0049-3848(14)50371-4. 2014
Prognostic Impact of Anthracycline Metabolism Gene Polymorphisms in Newly Diagnosed Acute Myeloid Leukemia Adults
Eduardo Megias, Juan; (...); Angel Sanz, Miguel
Article. 2014
Prognostic Impact of Cytarabine Pathway Gene Polymorphisms in Acute Myeloid Leukemia Adults Undergoing Induction Chemotherapy
Eduardo Megias, Juan; (...); Angel Sanz, Miguel
Article. 2014
PROGNOSTIC IMPACT OF TRANSPORTER GENE POLYMORPHISMS IN NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA ADULTS
Megias Vericat, J. E.; (...); Sanz, M. A.
Article. 2015
Quality of thawed plasma inactivated with methylene blue after 48-hour storage
Balaguer A; (...); Sanz MÁ
Letter. 10.1016/j.transci.2014.11.005. 2015
Single Nucleotide Polymorphisms, SNPs, Associated With the Efficacy and Security of Immunosuppressive Treatment in Heart Transplantation
Sanchez-Lazaro, I.; (...); Salvador-Sanz, A.
Article. 10.1016/j.healun.2014.01.392. 2014
SNPs and taxane toxicity in breast cancer patients
Bosó V; (...); Aliño SF
Article. 10.2217/PGS.14.127. 2014
Spanish Consensus on the Prevention and Treatment of Pseudomonas aeruginosa Bronchial Infections in Cystic Fibrosis Patients
Cantón R; (...); Solé A
Article. 10.1016/j.arbres.2014.09.021. 2015
Study of The Correlation Between Osteoporosis and Arthropathy in Haemophilia Patients Using Self-Organizing Maps
Querol-Fuentes, F.; (...); Bonanad, S.
Meeting Abstract. 2015
Study on the Linezolid Prescription According to the Approval of Indication in a University Hospital
Pérez-Cebrián M; (...); Llopis-González A
Article. 2015
THROMBIN GENERATION TEST IN PATIENTS UNDER NEW ORAL ANTICOAGULANTS (DABIGATRAN AND RIVAROXABAN)
Cabrera, N.; (...); Bonanad, S.
Meeting Abstract. 10.1016/S0049-3848(14)50148-X. 2014
Treatment adherence and other patient-reported outcomes as cost determinants in multiple sclerosis: a review of the literature
Lizan, L; (...); Polanco, C
Review. 10.2147/PPA.S67253. 2014